Impax Laboratories (IPXL) Reports Settlement of Contract Litigation on Opana ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets
Tweet Send to a Friend
Impax Laboratories, Inc. (NASDAQ: IPXL), today announced a Settlement Agreement to resolve a contract dispute relating to an agreement entered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
